Seven-day Repeated Dose Clinical Pharmacological Study of FYU-981 Administered to Hyperuricemia
Latest Information Update: 22 Jan 2024
At a glance
- Drugs Dotinurad (Primary) ; Topiroxostat
- Indications Hyperuricaemia
- Focus Pharmacodynamics
- Sponsors Fuji Yakuhin
- 01 Jan 2024 A Post hoc analysis based on data from this and NCT03375632 studies published in the Clinical Pharmacology in Drug Development
- 20 Aug 2018 Status changed from active, no longer recruiting to completed.
- 07 Sep 2017 Status changed from recruiting to active, no longer recruiting.